Cancer research
Teclistamab Shows Promise in Treating Elderly Adults with Relapsed/Refractory Multiple Myeloma
A recent study published in the Blood Cancer Journal suggests that teclistamab, a BCMA-directed bispecific antibody, is safe and efficacious in treating elderly adults with relapsed/refractory multiple myeloma (RRMM). The research, conducted by the University of Texas MD Anderson Cancer Center, analyzed a large cohort of 385 patients, of